remoxipride has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cory-Slechta, DA; Reeves, R; Thiruchelvam, M | 1 |
| Edsman, I; Holm, AC; Lundberg, T; Odlind, B | 1 |
| Lake-Bakaar, DM; Magnusson, O; Mohringe, B; Thorell, G | 1 |
| Farde, L; Grind, M; Nilsson, MI; Ogenstad, S; Sedvall, G | 1 |
1 trial(s) available for remoxipride and Body Weight
| Article | Year |
|---|---|
Tolerability of remoxipride in the long term treatment of schizophrenia. An overview.
Topics: Body Weight; Double-Blind Method; Female; Humans; Male; Prolactin; Remoxipride; Schizophrenia | 1993 |
3 other study(ies) available for remoxipride and Body Weight
| Article | Year |
|---|---|
Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
Topics: Animals; Behavior, Animal; Benzazepines; Body Weight; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; Piperazines; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Remoxipride; Serotonin; Triazoles | 2004 |
Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzamides; Body Weight; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride | 1987 |
Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzamides; Blood Pressure; Body Weight; Humans; Male; Movement Disorders; Prolactin; Pulse; Remoxipride | 1988 |